• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiviral adhesion molecular mechanisms for influenza: W. G. Laver's lifetime obsession

tetano

Editor, Senior Moderator
Philos Trans R Soc Lond B Biol Sci. 2015 Feb 5;370(1661). pii: 20140034.
[h=1]Antiviral adhesion molecular mechanisms for influenza: W. G. Laver's lifetime obsession.[/h] Garman EF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Infection by the influenza virus depends firstly on cell adhesion via the sialic-acid-binding viral surface protein, haemagglutinin, and secondly on the successful escape of progeny viruses from the host cell to enable the virus to spread to other cells. To achieve the latter, influenza uses another glycoprotein, the enzyme neuraminidase (NA), to cleave the sialic acid receptors from the surface of the original host cell. This paper traces the development of anti-influenza drugs, from the initial suggestion by MacFarlane Burnet in 1948 that an effective 'competitive poison' of the virus' NA might be useful in controlling infection by the virus, through to the determination of the structure of NA by X-ray crystallography and the realization of Burnet's idea with the design of NA inhibitors. A focus is the contribution of the late William Graeme Laver, FRS, to this research.
? 2014 The Author(s) Published by the Royal Society. All rights reserved.


[h=4]KEYWORDS:[/h] W. G. Laver; crystallography; influenza; neuraminidase; sialic acid

PMID: 25533092 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25533092
 
Back
Top Bottom